about
FAAP20: a novel ubiquitin-binding FA nuclear core-complex protein required for functional integrity of the FA-BRCA DNA repair pathwayFanconi anemia proteins and their interacting partners: a molecular puzzleRegulation of FANCD2 and FANCI monoubiquitination by their interaction and by DNA.Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathwayC. elegans ring finger protein RNF-113 is involved in interstrand DNA crosslink repair and interacts with a RAD51C homolog.The Fanconi Anemia DNA Repair Pathway Is Regulated by an Interaction between Ubiquitin and the E2-like Fold Domain of FANCLUbiquitin recognition by FAAP20 expands the complex interface beyond the canonical UBZ domain.Assessment of SLX4 Mutations in Hereditary Breast Cancers.Defective FANCI binding by a fanconi anemia-related FANCD2 mutant.Diagnosis of Fanconi anemia by diepoxybutane analysis.Common variants at VRK2 and TCF4 conferring risk of schizophrenia.Fanconi anemia proteins FANCD2 and FANCI exhibit different DNA damage responses during S-phaseMolecular pathways: turning proteasomal protein degradation into a unique treatment approach.Regulation of multiple DNA repair pathways by the Fanconi anemia protein SLX4.The Fanconi anemia pathway: repairing the link between DNA damage and squamous cell carcinoma.High incidence of female reproductive tract cancers in FA-deficient HPV16-transgenic mice correlates with E7's induction of DNA damage response, an activity mediated by E7's inactivation of pocket proteins.Posttranslational control of telomere maintenance and the telomere damage response.Readers of PCNA modificationsLysine-targeting specificity in ubiquitin and ubiquitin-like modification pathways.DNA damage repair machinery and HIV escape from innate immune sensing.Nuclease delivery: versatile functions of SLX4/FANCP in genome maintenance.Stress and DNA repair biology of the Fanconi anemia pathwayAssociation of human papillomavirus with Fanconi anemia promotes carcinogenesis in Fanconi anemia patients.RNA interferences targeting the Fanconi anemia/BRCA pathway upstream genes reverse cisplatin resistance in drug-resistant lung cancer cells.Histone chaperone activity of Fanconi anemia proteins, FANCD2 and FANCI, is required for DNA crosslink repair.BLM promotes the activation of Fanconi Anemia signaling pathway.Genotype-phenotype analysis of von Hippel-Lindau syndrome in fifteen Indian families.DNA robustly stimulates FANCD2 monoubiquitylation in the complex with FANCI.DNA damage-induced histone H1 ubiquitylation is mediated by HUWE1 and stimulates the RNF8-RNF168 pathway.Arabidopsis thaliana FANCD2 Promotes Meiotic Crossover Formation.Comprehensive review of genetic factors contributing to head and neck squamous cell carcinoma development in low-risk, nontraditional patients.An exploration of pathways involved in lung carcinoid progression using gene expression profiling.
P2860
Q24305406-0D4BF6B0-C244-4AA8-8E64-1261417986B2Q33353826-F2A6FE2F-E9F2-4B74-91F6-EA3CA517B2B9Q33635631-E7BDCD24-C8F3-4A42-BE26-25F23CA7E873Q34285356-0C39FA51-D21B-46EF-9426-F2F8E2B1CD13Q34337102-FA3D556C-EB8C-467B-9DCE-A0D709579CD7Q34483757-C68C0FF6-1BE7-4445-87B8-24DD249084ECQ34711904-4EBA3D75-6029-4527-B5D9-33A62EE371BBQ34806183-91784C78-A955-4547-8570-473397E767F6Q35502827-3A74245F-F739-4966-8ABD-5F56CEF96C0AQ35534473-7E76FBC6-C3C5-4890-A75B-6E3FBE43E0FFQ35816788-66830696-593F-4A4F-9FB2-EF4EF926CEA3Q36280755-567EAE89-B88D-40FB-A27A-8A181E49E2C9Q36436413-05B6E0B4-DBCC-4181-B863-CB734E5B2731Q36512615-9F080CF2-43B5-4B29-B797-64E568DB6F54Q36867985-FF1D40DC-444E-45E8-9D08-D9867EC02D71Q37722678-A0DEE011-8027-46AF-98C3-2BAE8875B35BQ37995466-C1EA1B55-FFE0-40D5-AE33-D5C302CAD36FQ38098472-335CA30A-A7CA-48DE-AD52-AF7F48BF07B7Q38201971-FC4D19B8-2E5A-47AB-B6AE-E8AA3D76B4B8Q38209320-2C6D1D5A-6C28-475F-8213-BB4546CA2F73Q38220992-26B13D6E-A450-403C-8C19-8FDC80B62EF8Q38252562-742C9E5D-246D-4730-8306-E71E54A2425AQ38380216-72CC044C-ABD9-4335-8E74-79526F98008AQ38834205-6056110A-0E8F-4B70-B8ED-33C502E8E234Q39308806-0A2A24B8-2664-4E1E-9A4B-4C7CE0826062Q39847864-79EA982F-5FDF-417C-AAA0-5DF8A5663BA0Q41754374-77A5A59A-BF20-4667-8CB1-2CD11C12395BQ42207392-2AC2D5D2-98C6-437A-9EEB-ECF0183B6FA5Q47209621-FEC43BEC-8225-4464-B712-F88192D8BBE3Q49911835-4E684342-28BC-4D03-814F-F56A0FD589C3Q50087551-5D245FD3-9C2D-45B7-817E-FC74E15A2FDAQ50728982-22C88984-658D-4908-A5CB-C4AAA2EF3120
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ubiquitylation and the Fanconi anemia pathway.
@en
Ubiquitylation and the Fanconi anemia pathway.
@nl
type
label
Ubiquitylation and the Fanconi anemia pathway.
@en
Ubiquitylation and the Fanconi anemia pathway.
@nl
prefLabel
Ubiquitylation and the Fanconi anemia pathway.
@en
Ubiquitylation and the Fanconi anemia pathway.
@nl
P2860
P1433
P1476
Ubiquitylation and the Fanconi anemia pathway.
@en
P2093
Elizabeth Garner
P2860
P304
P356
10.1016/J.FEBSLET.2011.04.078
P407
P577
2011-05-19T00:00:00Z